Skip to main content
Caplight Logo









Risen (Shanghai) Pharma Tech Co., Ltd.

Risen (Shanghai) Pharma Tech Co., Ltd.

Private
ShanghaiHealthcare & Life Scienceshttps://risen-pharma.com

Last Round

Debt

Oct 13, 2021

Total Funding Raised

$298.48M

Company Overview

Risen (Shanghai) Pharma Tech Co., Ltd. is a biotechnology company that develops and commercializes small molecule drugs, PROTACs, and siRNA therapeutics for neurodegenerative, metabolic, autoimmune, and oncological diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

biotechnologysmall moleculePROTACsiRNAdrug discoveryclinical-stage biotechoncologyneurodegenerative diseasedrug licensingbiopharmatherapeutic pipelinetranslational medicinedrug developmentprecision medicineclinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Risen (Shanghai) Pharma Tech Co., Ltd. Comparables

Compare Risen (Shanghai) Pharma Tech Co., Ltd. with similar companies based on industry and business-model similarity.

Risen (Shanghai) Pharma Tech Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ranok Therapeutics
78%
Sironax
76%
Accutar Biotechnology
74%

Risen (Shanghai) Pharma Tech Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtOct 13, 2021
Series BDec 1, 2020
Series AAug 1, 2015

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 1, 2020

    $57M round completed.

Risen (Shanghai) Pharma Tech Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Risen (Shanghai) Pharma Tech Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Risen (Shanghai) Pharma Tech Co., Ltd.'s valuation, stock price, and market status.

Is Risen (Shanghai) Pharma Tech Co., Ltd. a public or private company?

Risen (Shanghai) Pharma Tech Co., Ltd. is a private company.

What is the current stock price of Risen (Shanghai) Pharma Tech Co., Ltd.?

Risen (Shanghai) Pharma Tech Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Risen (Shanghai) Pharma Tech Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Risen (Shanghai) Pharma Tech Co., Ltd. worth (valuation)?

Valuation information for Risen (Shanghai) Pharma Tech Co., Ltd. is not publicly available.

Can I buy Risen (Shanghai) Pharma Tech Co., Ltd. stock?

Risen (Shanghai) Pharma Tech Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Risen (Shanghai) Pharma Tech Co., Ltd.'s last funding round?

Risen (Shanghai) Pharma Tech Co., Ltd.'s most recent funding round was Debt on October 13, 2021.

Who are the main investors in Risen (Shanghai) Pharma Tech Co., Ltd.?

Investor information for Risen (Shanghai) Pharma Tech Co., Ltd. is not publicly disclosed.

Will Risen (Shanghai) Pharma Tech Co., Ltd. IPO soon?

No public IPO plans have been announced for Risen (Shanghai) Pharma Tech Co., Ltd..

How can I track Risen (Shanghai) Pharma Tech Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades in Risen (Shanghai) Pharma Tech Co., Ltd.'s shares on secondary markets.

Firmographic Details

HeadquartersShanghai
Employee Range8
Year Founded2015
Last FundingOct 13, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?